These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 4042098)
1. Clinical quality assurance in the pharmaceutical industry. Donahue JJ Cancer Treat Rep; 1985 Oct; 69(10):1195-7. PubMed ID: 4042098 [No Abstract] [Full Text] [Related]
2. Bioequivalence/bioavailability retention samples. Ransom C Qual Assur; 1993; 2(1-2):42-3. PubMed ID: 8156218 [No Abstract] [Full Text] [Related]
3. Quality assurance operations: good clinical practices. Castellion AW Drug Inf J; 1983; 17(1):25-9. PubMed ID: 10262248 [TBL] [Abstract][Full Text] [Related]
4. Experiences with GLP/GCP from the pharmaceutical industry's viewpoint. Legler UF Methods Find Exp Clin Pharmacol; 1993 May; 15(4):233-6. PubMed ID: 8361261 [TBL] [Abstract][Full Text] [Related]
5. Clinical investigators and the pharmaceutical industry. Bellin E N Engl J Med; 2000 Aug; 343(7):511. PubMed ID: 10950676 [No Abstract] [Full Text] [Related]
6. Auditing clinical research data: objectives, applications and results. Justice RL Drug Inf J; 1983; 17(1):31-8. PubMed ID: 10262249 [TBL] [Abstract][Full Text] [Related]
7. New clinical trials policy at FDA. Vastag B Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196 [No Abstract] [Full Text] [Related]
8. Process analytical technology and ASTM Committee E55. Watts DC; Afnan AM; Hussain AS Stand News; 2004 May; 32(5):25-7. PubMed ID: 15146856 [No Abstract] [Full Text] [Related]
9. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321 [TBL] [Abstract][Full Text] [Related]
10. Quality assurance in a cooperative group. Wolter JM Cancer Treat Rep; 1985 Oct; 69(10):1189-93. PubMed ID: 4042097 [TBL] [Abstract][Full Text] [Related]
11. The regulation of biopharmaceuticals. Weisbroth N Qual Assur; 1993; 2(1-2):147-51. PubMed ID: 8156202 [No Abstract] [Full Text] [Related]
12. Pharmaceutical GMPs. Bobrowicz G Qual Assur; 1994 Jun; 3(2):138-48. PubMed ID: 7804629 [No Abstract] [Full Text] [Related]
13. Innovation and compliance are not diametrically opposed. Raab GK Qual Assur; 1994 Mar; 3(1):2-8. PubMed ID: 7804614 [No Abstract] [Full Text] [Related]
14. [Implementation of new Japanese GCP and the quality of clinical trials--from the standpoint of the pharmaceutical industry]. Ebi O Gan To Kagaku Ryoho; 1997 Oct; 24(13):1883-91. PubMed ID: 9350232 [TBL] [Abstract][Full Text] [Related]
15. Reply to 'Truth in numbers'. Kim PS Nat Med; 2006 Mar; 12(3):269. PubMed ID: 16520764 [No Abstract] [Full Text] [Related]
16. FDA tells senators of doctors who fake data in clinical drug trials. Holden C Science; 1979 Oct; 206(4417):423-3. PubMed ID: 504984 [No Abstract] [Full Text] [Related]
17. Guidelines and policies for medical writers in the biotech industry: an update on the controversy. Foote M Biotechnol Annu Rev; 2004; 10():259-64. PubMed ID: 15504710 [TBL] [Abstract][Full Text] [Related]
18. Barriers to clinical trials vary according to the type of trial and the institution. Govindarajan R; Young JW; Harless CL; Hutchins LF J Clin Oncol; 2007 Apr; 25(12):1633-4; author reply 1634. PubMed ID: 17443010 [No Abstract] [Full Text] [Related]
19. Trouble at the office. Allison M Nat Biotechnol; 2008 Sep; 26(9):967-9. PubMed ID: 18779797 [No Abstract] [Full Text] [Related]
20. Ethics. Clinical trials guidelines at odds with U.S. policy. Normile D Science; 2008 Oct; 322(5901):516. PubMed ID: 18948510 [No Abstract] [Full Text] [Related] [Next] [New Search]